Washington, DC 20006-5349
HELPLINE
Results from studies using PDL1 inhibitors Today, at the World Conference on Lung Cancer 2016 (Mesothelioma Track), several investigators presented data for their immunotherapy studies.…
“Mesothelioma is known as a traditionally under-funded and under-studied cancer.” That’s the answer customarily given to patients, their families, and the public at large when…
This week, representatives of the Mesothelioma Applied Research Foundation are attending one of the largest medical conferences in the world: the World Conference on Lung…
by Marcia Schekel A diagnosis … mesothelioma … a punch to the gut … frozen with fear. Mine was April 2014: surgical biopsy, pleural mesothelioma…
Charity Navigator has awarded the Meso Foundation its highest rating, reserved for organizations that exceed industry standards and outperform most charities in their cause. Charity…
As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of…
On April 26, we had the opportunity to attend Bloomberg Government’s conference on Building the Big Data Economy: Personalized care and cancer treatment in the…
For cancer patients, a diagnosis is generally followed by staging. Among other things, the stage of a cancer tells the patient and physician if the…
Just today, we learned that Verastem, a biotech company that has previously done research in mesothelioma, has now embarked on several new projects. In the…
In the latest iteration of its budget bill, Congress included $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP). The…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
